Source:http://linkedlifedata.com/resource/pubmed/id/16925686
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2006-8-23
|
pubmed:abstractText |
Probiotics are immunomodulatory and may thus affect vaccine antibody responses. With the accumulating evidence of their health-promoting effects, probiotics are increasingly administered in allergy-prone infants. Therefore, we studied the effect of probiotics on antibody responses to diphtheria, tetanus and Haemophilus influenzae type b (Hib) vaccines in 6-month-old infants participating in a randomized placebo-controlled double-blind allergy-prevention trial. Mothers of unborn children at increased risk for atopy used a combination of four probiotic strains, or a placebo, for 4 wk before delivery. During 6 months from birth, their infants received the same probiotics and galacto-oligosaccharides, or a placebo. The infants were immunized with a DTwP (diphtheria, tetanus and whole cell pertussis) at ages 3, 4, and 5 months, and with a Hib polysaccharide conjugate at 4 months. Serum diphtheria, tetanus, and Hib IgG antibodies were measured at 6 months. In the probiotic group, protective Hib antibody concentrations (>/=1 microg/ml) occurred more frequently, 16 of 32 (50%) vs. six of 29 (21%) (p = 0.020), and the geometric mean (inter-quartile range) Hib IgG concentration tended to be higher 0.75 (0.15-2.71) microg/ml than in the placebo group 0.40 (0.15-0.92) microg/ml (p = 0.064). In these respective groups, diphtheria, 0.38 (0.14-0.78) vs. 0.47 (0.19-1.40) IU/ml (p = 0.449), and tetanus, 1.01(0.47-1.49) vs. 0.81 (0.56-1.39) IU/ml (p = 0.310), IgG titers were comparable. In conclusion, in allergy-prone infants probiotics seem not to impair antibody responses to diphtheria, tetanus, or Hib, but may improve response to Hib immunization.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0905-6157
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
416-21
|
pubmed:dateRevised |
2008-5-28
|
pubmed:meshHeading |
pubmed-meshheading:16925686-Bifidobacterium,
pubmed-meshheading:16925686-Diphtheria-Tetanus-Pertussis Vaccine,
pubmed-meshheading:16925686-Double-Blind Method,
pubmed-meshheading:16925686-Female,
pubmed-meshheading:16925686-Haemophilus Vaccines,
pubmed-meshheading:16925686-Humans,
pubmed-meshheading:16925686-Immunoglobulin G,
pubmed-meshheading:16925686-Infant,
pubmed-meshheading:16925686-Lactobacillus rhamnosus,
pubmed-meshheading:16925686-Male,
pubmed-meshheading:16925686-Oligosaccharides,
pubmed-meshheading:16925686-Pregnancy,
pubmed-meshheading:16925686-Probiotics,
pubmed-meshheading:16925686-Propionibacterium
|
pubmed:year |
2006
|
pubmed:articleTitle |
Effect of probiotics on vaccine antibody responses in infancy--a randomized placebo-controlled double-blind trial.
|
pubmed:affiliation |
Skin and Allergy Hospital, University of Helsinki, Helsinki, Finland. kaarina.kukkonen@hus.fi
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|